NCT02348775
|
2014-11-01 |
Glutathione and Function in HIV Patients
|
Phase 1
|
Recruiting
|
NCT02348762
|
2014-11-01 |
Energetics and Function in Older Humans
|
Phase 1
|
Recruiting
|
NCT02252341
|
2014-09-01 |
Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder
|
Phase 4
|
Enrolling By Invitation
|
NCT02206152
|
2014-07-01 |
A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
|
Phase 1/Phase 2
|
Not Yet Recruiting
|
NCT02117700
|
2014-05-01 |
Fatty Liver Disease in Obese Children
|
Phase 2
|
Not Yet Recruiting
|
NCT02050139
|
2014-02-01 |
L-Cysteine in Peritoneal Dialysis
|
Phase 2
|
Recruiting
|
NCT02124941
|
2014-02-01 |
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS
|
Phase 1
|
Recruiting
|
NCT01840345
|
2014-01-01 |
The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain
|
Phase 2
|
Recruiting
|
NCT01820195
|
2013-03-01 |
N-Acetyl Cystein and Contrast Nephropathy
|
Phase 3
|
Recruiting
|
NCT01841411
|
2013-03-01 |
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
|
Phase 4
|
Recruiting
|
NCT01878669
|
2013-01-01 |
Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
|
Phase 3
|
Recruiting
|
NCT01797575
|
2013-01-01 |
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
|
Phase 2
|
Recruiting
|
NCT01063348
|
2012-09-01 |
N-Acetyl Cysteine in Pathologic Skin Picking
|
Phase 2
|
Recruiting
|
NCT02239107
|
2012-01-01 |
N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome
|
Phase 4
|
Completed
|
NCT01339858
|
2011-05-01 |
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
|
Phase 4
|
Recruiting
|
NCT01403506
|
2011-04-01 |
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
|
Phase 3
|
Recruiting
|
NCT01614431
|
2011-03-01 |
N Acetyl Cysteine for Cystinosis Patients
|
Phase 4
|
Completed
|
NCT01322009
|
2011-03-01 |
Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury
|
Phase 1/Phase 2
|
Recruiting
|
NCT01251315
|
2010-12-01 |
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels
|
Phase 1
|
Completed
|
NCT01241513
|
2010-11-01 |
Induced Changes in Ventilatory Responsiveness and Altitude Exposure
|
Phase 4
|
Completed
|
NCT01355198
|
2010-08-01 |
Role of HIV on Glutathione Synthesis and Oxidative Stress
|
Phase 1
|
Completed
|
NCT01099332
|
2009-11-01 |
Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT00967005
|
2009-09-01 |
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2
|
Active, Not Recruiting
|
NCT00975689
|
2009-08-01 |
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
|
Phase 1/Phase 2
|
Completed
|
NCT00866866
|
2009-03-01 |
The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms
|
Phase 4
|
Recruiting
|
NCT00829205
|
2009-01-01 |
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
|
Phase 1/Phase 2
|
Withdrawn
|
NCT00676195
|
2008-06-01 |
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
|
Phase 2
|
Completed
|
NCT00627705
|
2008-02-01 |
A Study of N-Acetyl Cysteine in Children With Autism
|
Phase 2
|
Completed
|
NCT00489372
|
2007-07-01 |
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
|
Phase 1
|
Completed
|
NCT00254176
|
2006-09-01 |
Cysteine Supplementation in Critically Ill Neonates
|
Phase 2/Phase 3
|
Active, Not Recruiting
|
NCT00354770
|
2006-07-01 |
N-Acetyl Cysteine in Trichotillomania
|
Phase 2
|
Completed
|
NCT00332605
|
2006-06-01 |
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
|
Phase 2
|
Completed
|
NCT00273702
|
2006-01-01 |
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
|
Phase 1
|
Completed
|
NCT00863785
|
2004-04-01 |
Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone
|
Phase 3
|
Completed
|
NCT01506765
|
2003-08-01 |
Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia
|
Phase 1
|
Completed
|
NCT00004940
|
1996-05-01 |
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
|
Phase 3
|
Completed
|